Annual ROE
-61.86%
-49.20%-388.63%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual return on equity is -61.86%, with the most recent change of -49.20% (-388.63%) on December 1, 2023.
- During the last 3 years, CATX annual ROE has fallen by -52.60% (-568.03%).
- CATX annual ROE is now -101.22% below its all-time high of 5062.08%, reached on June 1, 2005.
Performance
CATX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-26.18%
+5.51%+17.39%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly return on equity is -26.18%, with the most recent change of +5.51% (+17.39%) on September 1, 2024.
- Over the past year, CATX quarterly ROE has dropped by -6.05% (-30.05%).
- CATX quarterly ROE is now -104.18% below its all-time high of 625.76%, reached on December 1, 2005.
Performance
CATX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CATX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -388.6% | -30.1% |
| 3 y3 years | -568.0% | -217.3% |
| 5 y5 years | +23.6% | -217.3% |
CATX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -568.0% | at low | -217.3% | +43.6% |
| 5 y | 5-year | -568.0% | +23.6% | -217.3% | +53.4% |
| alltime | all time | -101.2% | +58.5% | -104.2% | +96.6% |
Perspective Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -26.18%(-17.4%) |
| Jun 2024 | - | -31.69%(-30.5%) |
| Mar 2024 | - | -45.60%(-1.8%) |
| Dec 2023 | -61.86%(+388.6%) | -46.43%(+130.7%) |
| Sep 2023 | - | -20.13%(+22.7%) |
| Jun 2023 | - | -16.40%(+98.8%) |
| Mar 2023 | - | -8.25%(-43.3%) |
| Dec 2022 | -12.66%(+12.0%) | - |
| Sep 2022 | - | -14.56%(+29.0%) |
| Jun 2022 | - | -11.29%(+18.7%) |
| Jun 2022 | -11.30%(+22.0%) | - |
| Mar 2022 | - | -9.51%(-6.3%) |
| Dec 2021 | - | -10.15%(-9.5%) |
| Sep 2021 | - | -11.22%(+5.5%) |
| Jun 2021 | -9.26%(-82.0%) | - |
| Jun 2021 | - | -10.64%(-41.0%) |
| Mar 2021 | - | -18.02%(-61.3%) |
| Dec 2020 | - | -46.61%(-17.1%) |
| Sep 2020 | - | -56.22%(+5.4%) |
| Jun 2020 | -51.42%(-36.5%) | -53.32%(+12.0%) |
| Mar 2020 | - | -47.62%(-5.5%) |
| Dec 2019 | - | -50.38%(-0.4%) |
| Sep 2019 | - | -50.57%(-17.2%) |
| Jun 2019 | -80.94%(-5.6%) | -61.10%(-21.7%) |
| Mar 2019 | - | -78.08%(-4.8%) |
| Dec 2018 | - | -82.05%(-2.0%) |
| Sep 2018 | - | -83.74%(-1.8%) |
| Jun 2018 | -85.72%(+87.8%) | -85.31%(+28.0%) |
| Mar 2018 | - | -66.65%(+14.4%) |
| Dec 2017 | - | -58.24%(+13.5%) |
| Sep 2017 | - | -51.30%(+12.8%) |
| Jun 2017 | -45.64%(+80.1%) | -45.46%(+23.7%) |
| Mar 2017 | - | -36.76%(+11.8%) |
| Dec 2016 | - | -32.88%(+10.6%) |
| Sep 2016 | - | -29.72%(+17.5%) |
| Jun 2016 | -25.34%(+53.9%) | -25.30%(+9.1%) |
| Mar 2016 | - | -23.20%(+11.0%) |
| Dec 2015 | - | -20.91%(+15.5%) |
| Sep 2015 | - | -18.10%(+10.4%) |
| Jun 2015 | -16.46%(-59.5%) | -16.39%(-11.9%) |
| Mar 2015 | - | -18.61%(-31.0%) |
| Dec 2014 | - | -26.99%(-15.3%) |
| Sep 2014 | - | -31.85%(-27.4%) |
| Jun 2014 | -40.65%(-41.1%) | -43.90%(-16.3%) |
| Mar 2014 | - | -52.48%(-12.3%) |
| Dec 2013 | - | -59.87%(-0.7%) |
| Sep 2013 | - | -60.27%(+2.2%) |
| Jun 2013 | -68.96%(+21.3%) | -58.97%(-2.9%) |
| Mar 2013 | - | -60.75%(+5.2%) |
| Dec 2012 | - | -57.74%(+10.1%) |
| Sep 2012 | - | -52.45%(-8.2%) |
| Jun 2012 | -56.87% | -57.15%(+20.1%) |
| Mar 2012 | - | -47.57%(-14.0%) |
| Dec 2011 | - | -55.33%(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | -51.11%(+10.9%) |
| Jun 2011 | -44.94%(-10.0%) | -46.09%(-9.7%) |
| Mar 2011 | - | -51.04%(+2.3%) |
| Dec 2010 | - | -49.90%(-10.4%) |
| Sep 2010 | - | -55.70%(+11.9%) |
| Jun 2010 | -49.93%(+4.3%) | -49.78%(+7.6%) |
| Mar 2010 | - | -46.28%(+2.6%) |
| Dec 2009 | - | -45.10%(-2.8%) |
| Sep 2009 | - | -46.41%(-4.3%) |
| Jun 2009 | -47.87%(+7.7%) | -48.52%(+7.9%) |
| Mar 2009 | - | -44.98%(+0.5%) |
| Dec 2008 | - | -44.77%(-4.1%) |
| Sep 2008 | - | -46.66%(+5.1%) |
| Jun 2008 | -44.46%(-40.7%) | -44.38%(-5.2%) |
| Mar 2008 | - | -46.81%(-10.2%) |
| Dec 2007 | - | -52.14%(-5.9%) |
| Sep 2007 | - | -55.40%(-29.7%) |
| Jun 2007 | -75.03%(-35.6%) | -78.84%(-29.5%) |
| Mar 2007 | - | -111.87%(-53.0%) |
| Dec 2006 | - | -237.77%(-41.6%) |
| Sep 2006 | - | -407.13%(-47.0%) |
| Jun 2006 | -116.42%(-102.3%) | -767.47%(+17.0%) |
| Mar 2006 | - | -655.70%(-204.8%) |
| Dec 2005 | - | 625.76%(+338.7%) |
| Sep 2005 | - | 142.63%(-249.8%) |
| Jun 2005 | 5062.08%(<-9900.0%) | - |
| Mar 2005 | - | -95.20%(<-9900.0%) |
| Dec 2004 | - | 0.44%(-102.8%) |
| Sep 2004 | -19.35%(-282.0%) | -15.81%(+18.1%) |
| Jun 2004 | - | -13.39%(+55.5%) |
| Mar 2004 | - | -8.61%(+73.6%) |
| Dec 2003 | - | -4.96%(-168.3%) |
| Sep 2003 | 10.63%(+94.7%) | 7.26%(+10.8%) |
| Jun 2003 | - | 6.55%(+12.5%) |
| Mar 2003 | - | 5.82%(-3.8%) |
| Dec 2002 | - | 6.05%(+9.2%) |
| Sep 2002 | 5.46%(-124.0%) | 5.54%(-124.3%) |
| Jun 2002 | - | -22.83%(+10.3%) |
| Mar 2002 | - | -20.69%(+3.7%) |
| Dec 2001 | - | -19.95%(+5.5%) |
| Sep 2001 | -22.77%(-544.7%) | -18.91%(-411.0%) |
| Jun 2001 | - | 6.08%(+14.3%) |
| Mar 2001 | - | 5.32%(0.0%) |
| Dec 2000 | - | 5.32%(+1.9%) |
| Sep 2000 | 5.12%(-103.4%) | 5.22%(-103.6%) |
| Jun 2000 | - | -144.72%(-0.4%) |
| Mar 2000 | - | -145.25%(-0.4%) |
| Dec 1999 | - | -145.88%(-51.3%) |
| Sep 1999 | -149.05%(-2382.5%) | -299.61% |
| Sep 1998 | 6.53%(-68.3%) | - |
| Sep 1997 | 20.57%(-81.8%) | - |
| Sep 1996 | 113.10%(-22.5%) | - |
| Sep 1995 | 145.95%(-198.6%) | - |
| Sep 1994 | -147.99% | - |
FAQ
- What is Perspective Therapeutics annual return on equity?
- What is the all time high annual ROE for Perspective Therapeutics?
- What is Perspective Therapeutics annual ROE year-on-year change?
- What is Perspective Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly ROE year-on-year change?
What is Perspective Therapeutics annual return on equity?
The current annual ROE of CATX is -61.86%
What is the all time high annual ROE for Perspective Therapeutics?
Perspective Therapeutics all-time high annual return on equity is 5062.08%
What is Perspective Therapeutics annual ROE year-on-year change?
Over the past year, CATX annual return on equity has changed by -49.20% (-388.63%)
What is Perspective Therapeutics quarterly return on equity?
The current quarterly ROE of CATX is -26.18%
What is the all time high quarterly ROE for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly return on equity is 625.76%
What is Perspective Therapeutics quarterly ROE year-on-year change?
Over the past year, CATX quarterly return on equity has changed by -6.05% (-30.05%)